| ZOMEBON IV INFUZYON ICIN KONSANTRE COZELTI ICEREN KULLANIMA HAZIR SIRINGA 4 mg/5 ml 1x5 ml enjektör | |||||||||
| Tarih |
Etiket Fiyat |
Kamu Fiyat |
KKİ Oranı |
Depocu Fiyat |
İmalatçı Fiyat |
Eşdeğer Kod |
Referans Grup |
Değişim Türü |
|
| 24.07.2023 | 1.574,31 | 1.206,27 | 1.175,17 | TİTCK | |||||
| 10.07.2023 | 1.226,09 | 926,13 | 900,52 | TİTCK | |||||
| 14.03.2023 | 1.203,80 | 926,13 | 900,52 | TİTCK | |||||
| 16.02.2023 | 1.175,54 | 926,13 | 900,52 | SGK | |||||
| 15.12.2022 | 1.175,54 | 926,13 | 900,52 | E375A | TR-026A | TİTCK | |||
| 12.10.2022 | 874,18 | 679,19 | 658,43 | E375A | TR-026A | TİTCK | |||
| 19.07.2022 | 851,94 | 679,19 | 658,43 | E375A | TR-026A | TİTCK | |||
| 09.07.2022 | 851,93 | 679,19 | 658,43 | E375A | TR-026A | TİTCK | |||
| 14.04.2022 | 678,69 | 544,88 | 526,75 | E375A | TR-026A | SGK | |||
| 19.02.2022 | 678,69 | 488,66 | 28,00% | 544,88 | 526,75 | E375A | TR-026A | TİTCK | |
| 20.02.2021 | 501,68 | 361,21 | 28,00% | 398,54 | 383,28 | E375A | TR-026A | TİTCK | |
| 19.02.2020 | 422,86 | 304,46 | 28,00% | 333,38 | 319,40 | E375A | TR-026A | TİTCK | |
| 19.02.2019 | 380,33 | 273,84 | 28,00% | 298,22 | 284,93 | E375A | TR-026A | TİTCK | |
| 31.05.2018 | 306,97 | 227,16 | 26,00% | 237,57 | 225,47 | E375A | TR-026A | TİTCK | |
| 19.02.2018 | 306,97 | 221,02 | 28,00% | 237,57 | 225,47 | E375A | TR-026A | TİTCK | |
| 31.01.2018 | 270,43 | 194,71 | 28,00% | 207,51 | 196,07 | E375A | TR-026A | SGK | |
| 20.02.2017 | 270,43 | 194,71 | 28,00% | 207,51 | 196,07 | E375A | TİTCK | ||
| 31.01.2017 | 245,84 | 177,00 | 28,00% | 187,88 | 177,20 | E375A | TİTCK | ||
| 23.02.2016 | 302,22 | 217,60 | 28,00% | 233,65 | 221,62 | E375A | SGK | ||
| 22.02.2016 | 302,22 | 217,60 | 28,00% | 233,65 | 221,62 | E375A | TİTCK | ||
| 04.09.2015 | 297,33 | 214,08 | 28,00% | 229,61 | 217,66 | E375A | TİTCK | ||
| 01.06.2015 | 287,17 | 206,76 | 28,00% | 221,20 | 209,42 | E375A | TİTCK | ||
| 11.04.2015 | 281,94 | 203,00 | 28,00% | 216,88 | 205,18 | E375A | SGK | ||
| 10.04.2015 | 281,94 | 216,88 | 205,18 | TİTCK | |||||